[PHARMA] QoQ Quarter Result on 31-Dec-2020 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
17-Mar-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Dec-2020 [#4]
Profit Trend
QoQ- -539.04%
YoY- 96.46%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 2,132,675 1,177,123 793,499 634,583 624,804 645,763 819,921 89.02%
PBT 98,219 22,244 31,524 -13,506 4,093 14,326 30,880 116.12%
Tax -47,895 -8,356 -8,696 6,459 -2,799 -4,719 -8,465 217.18%
NP 50,324 13,888 22,828 -7,047 1,294 9,607 22,415 71.37%
-
NP to SH 49,835 13,704 23,136 -6,331 1,442 9,979 22,399 70.34%
-
Tax Rate 48.76% 37.57% 27.59% - 68.39% 32.94% 27.41% -
Total Cost 2,082,351 1,163,235 770,671 641,630 623,510 636,156 797,506 89.50%
-
Net Worth 391,428 357,275 355,919 337,298 345,040 357,891 350,047 7.72%
Dividend
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Div 26,182 19,630 10,468 2,614 3,920 6,530 15,673 40.74%
Div Payout % 52.54% 143.25% 45.25% 0.00% 271.91% 65.45% 69.98% -
Equity
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Net Worth 391,428 357,275 355,919 337,298 345,040 357,891 350,047 7.72%
NOSH 1,309,126 261,991 261,705 261,705 261,705 261,705 261,229 192.55%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 2.36% 1.18% 2.88% -1.11% 0.21% 1.49% 2.73% -
ROE 12.73% 3.84% 6.50% -1.88% 0.42% 2.79% 6.40% -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 162.91 89.95 303.20 242.70 239.03 247.20 313.87 -35.38%
EPS 3.81 1.05 8.84 -2.42 0.55 3.82 8.57 -41.72%
DPS 2.00 1.50 4.00 1.00 1.50 2.50 6.00 -51.89%
NAPS 0.299 0.273 1.36 1.29 1.32 1.37 1.34 -63.17%
Adjusted Per Share Value based on latest NOSH - 261,705
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 147.98 81.67 55.06 44.03 43.35 44.81 56.89 89.02%
EPS 3.46 0.95 1.61 -0.44 0.10 0.69 1.55 70.71%
DPS 1.82 1.36 0.73 0.18 0.27 0.45 1.09 40.70%
NAPS 0.2716 0.2479 0.247 0.234 0.2394 0.2483 0.2429 7.72%
Price Multiplier on Financial Quarter End Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 -
Price 0.835 5.29 3.26 5.00 4.32 2.22 1.26 -
P/RPS 0.51 5.88 1.08 2.06 1.81 0.90 0.40 17.56%
P/EPS 21.93 505.18 36.88 -206.50 783.09 58.12 14.69 30.58%
EY 4.56 0.20 2.71 -0.48 0.13 1.72 6.81 -23.44%
DY 2.40 0.28 1.23 0.20 0.35 1.13 4.76 -36.62%
P/NAPS 2.79 19.38 2.40 3.88 3.27 1.62 0.94 106.39%
Price Multiplier on Announcement Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 19/11/21 20/08/21 21/05/21 17/03/21 19/11/20 19/08/20 19/05/20 -
Price 0.845 0.925 4.03 3.49 5.72 4.42 1.88 -
P/RPS 0.52 1.03 1.33 1.44 2.39 1.79 0.60 -9.09%
P/EPS 22.20 88.34 45.59 -144.14 1,036.87 115.71 21.93 0.81%
EY 4.51 1.13 2.19 -0.69 0.10 0.86 4.56 -0.73%
DY 2.37 1.62 0.99 0.29 0.26 0.57 3.19 -17.95%
P/NAPS 2.83 3.39 2.96 2.71 4.33 3.23 1.40 59.80%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment